ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

Richard Bloch, advocate for patient information services, dead at 78.

July 30, 2004

Opioid Pain Reliever Approved With Risk Reduction Plan

July 31, 2009

In Brief: NCI’s Cutler Clarifies Policy On Release Of Survey Data, Tape Duplicates Will Be Available At Cost

September 6, 1974

Cancer Society, With Level Budget, Cuts On More Money to Fund “Pay Ifs” In FY92

March 27, 1992

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

September 23, 1983